IDIBAPS participates in the Graphene Flagship
In the context of the Graphene Week 2014, the European Commission announced that the Graphene Flagship, one of the largest European research initia...
News from 2014
Type 2 diabetic patients are better controlled with insulin pumps
Efficacy results from the comparison between the use of insulin pumps and multiple injections (OpT2mise trial) could define how this treatment can...
A mutation in progenitor cells identified as origin and therapeutic target for cholangiocarcinoma
In recent years, cancer research has been focused on the identification of mutations in genes involved in tumor development. Nevertheless, the mole...
Five researchers from IDIBAPS among the most cited scientists
Thomson Reuters has published the list of the Highly Cited Researchers, a compilation of the most influential names in science. 50 Spanish researc...
An UB research shows that cholesterol plays a key role in cell migration
A group of researchers led by professor Carles Enrich, Chief of IDIBAPS' Endocytosis and Protein Intracellular Transit team and member of Cellula...
IDIBAPS researchers identified a new neurodegenerative disease related to sleep disorders
Discover how the brain, memory, or what tools works allow you to identify behavioral disorders are some of the challenges facing the neuroimmunol...
IDIBAPS welcomes the third meeting of COST Action BM1206 for genetic studies of colorectal cancer
Colorectal cancer (CRC) is one of the most frequent neoplasms worldwide and an important cause of morbidity in the developed world. It is necessary...